CAR T-Cell Therapy

>

Latest News

Coordination Is Essential During and After Referral for CAR T in Myeloma
Coordination Is Essential During and After Referral for CAR T in Myeloma

June 11th 2025

During a live event, Konstantinos Sdrimas, MD, and community oncologists discussed patient concerns over CAR T-cell therapy toxicity and how to coordinate with CAR T providers.

Bridging and BCMA Exposure Impact Ide-Cel Outcomes in Multiple Myeloma
Bridging and BCMA Exposure Impact Ide-Cel Outcomes in Multiple Myeloma

June 9th 2025

Social, Logistical Barriers Limit Use of CAR T-Cell Therapy in Myeloma
Social, Logistical Barriers Limit Use of CAR T-Cell Therapy in Myeloma

May 29th 2025

PFS Benefit of Ide-cel in Myeloma Maintained in Higher-Risk Population
PFS Benefit of Ide-cel in Myeloma Maintained in Higher-Risk Population

May 27th 2025

Roundtable Roundup: Early CAR T-cell Therapy in Multiple Myeloma
Roundtable Roundup: Early CAR T-cell Therapy in Multiple Myeloma

May 19th 2025

More News